Terug
41
Dagbereik
€ 67,02
€ 68,55
52-Weeksbereik
€ 66,49
€ 107,27
Volume
1.152.697
50D / 200D Gem.
€ 78,50
/
€ 84,96
Vorige Slotkoers
€ 66,71
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 31,5 | 0,4 |
| P/B | 2,6 | 2,9 |
| ROE % | 8,7 | 3,8 |
| Net Margin % | 8,5 | 3,9 |
| Rev Growth 5Y % | 9,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 100,67
+47.8%
Low: € 78,00
High: € 108,00
Forward K/W
16,8
Forward WPA
€ 4,06
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,6 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,23
€ 5,16 – € 5,31
|
2,1 B | 1 |
| FY2029 |
€ 4,97
€ 4,90 – € 5,05
|
1,9 B | 1 |
| FY2028 |
€ 4,65
€ 4,44 – € 4,85
|
1,8 B | 2 |
Belangrijkste Punten
Revenue grew 8,98% annually over 5 years — modest growth
Generating 215,65M in free cash flow
P/E of 31,51 — premium valuation
Cash machine — converts 167,84% of earnings into free cash flow
Capital efficient — spends only 5,39% of revenue on capex
Groei
Revenue Growth (5Y)
8,98%
Revenue (1Y)11,75%
Earnings (1Y)6,76%
FCF Growth (3Y)41,01%
Kwaliteit
Return on Equity
8,67%
ROIC5,58%
Net Margin8,48%
Op. Margin12,19%
Veiligheid
Debt / Equity
0,57
Current Ratio4,34
Interest Coverage6,98
Waardering
P/E Ratio
31,51
P/B Ratio2,56
EV/EBITDA24,35
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,75% | Revenue Growth (3Y) | 9,80% |
| Earnings Growth (1Y) | 6,76% | Earnings Growth (3Y) | 16,66% |
| Revenue Growth (5Y) | 8,98% | Earnings Growth (5Y) | 27,61% |
| Profitability | |||
| Revenue (TTM) | 1,52B | Net Income (TTM) | 128,49M |
| ROE | 8,67% | ROA | 4,78% |
| Gross Margin | 48,70% | Operating Margin | 12,19% |
| Net Margin | 8,48% | Free Cash Flow (TTM) | 215,65M |
| ROIC | 5,58% | FCF Growth (3Y) | 41,01% |
| Safety | |||
| Debt / Equity | 0,57 | Current Ratio | 4,34 |
| Interest Coverage | 6,98 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 31,51 | P/B Ratio | 2,56 |
| P/S Ratio | 2,67 | PEG Ratio | 8,40 |
| EV/EBITDA | 24,35 | Dividend Yield | 0,00% |
| Market Cap | 4,05B | Enterprise Value | 4,50B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,52B | 1,36B | 1,26B | 1,15B | 1,07B |
| Net Income | 128,49M | 120,36M | 94,41M | 74,52M | 48,45M |
| EPS (Diluted) | 2,13 | 2,03 | 1,62 | 1,29 | 0,84 |
| Gross Profit | 738,27M | 643,33M | 583,87M | 519,10M | 485,33M |
| Operating Income | 184,72M | 155,69M | 123,94M | 87,56M | 60,92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,69B | 2,42B | 2,33B | 1,66B | 1,65B |
| Total Liabilities | 1,10B | 1,04B | 1,12B | 519,57M | 608,50M |
| Shareholders' Equity | 1,58B | 1,38B | 1,20B | 1,14B | 1,04B |
| Total Debt | 898,23M | 794,67M | 891,36M | 279,76M | 325,70M |
| Cash & Equivalents | 448,50M | 376,72M | 587,04M | 58,41M | 67,75M |
| Current Assets | 1,04B | 923,77M | 1,11B | 529,08M | 482,21M |
| Current Liabilities | 239,76M | 216,40M | 203,56M | 220,65M | 236,28M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#594 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026